SUPV:NYSEGrupo Supervielle S.A. Analysis
Data as of 2026-05-03 - not real-time
$7.89
Latest Price
8/10Risk
Risk Level: High
Executive Summary
SUPV trades at $7.89, hugging the computed support of $7.66, with a 30‑day RSI of ~30 indicating oversold conditions. The MACD histogram is negative and the signal line is bearish, suggesting short‑term momentum weakness. However, volatility is extreme at 62% over the past month and beta exceeds 2.5, flagging heightened sensitivity to market swings. The forward P/E of 5.98 is well below the industry average of 17.5, while the DCF model projects a fair value of over $43,000 per share, implying a theoretical upside of more than 60%. Recent filings show the company submitted its 2025 Form 20‑F and the Q4 earnings call disclosed a net loss that, while still sizable, improved markedly from the prior quarter.
The balance sheet holds over $670 billion in cash against $1.13 trillion of debt, giving a zero‑debt‑to‑equity ratio but a stressed leverage profile. No dividend is paid, eliminating income yield. Analyst consensus is a “hold” with a median price target around $13, far below the DCF estimate. Given the combination of deep valuation discount, improving earnings outlook, and substantial liquidity, the stock presents a speculative upside if macro‑economic conditions in Argentina stabilize. Nonetheless, the high beta, acute volatility, and sovereign risks keep the risk profile elevated.
The balance sheet holds over $670 billion in cash against $1.13 trillion of debt, giving a zero‑debt‑to‑equity ratio but a stressed leverage profile. No dividend is paid, eliminating income yield. Analyst consensus is a “hold” with a median price target around $13, far below the DCF estimate. Given the combination of deep valuation discount, improving earnings outlook, and substantial liquidity, the stock presents a speculative upside if macro‑economic conditions in Argentina stabilize. Nonetheless, the high beta, acute volatility, and sovereign risks keep the risk profile elevated.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Oversold RSI near 30
- Price at technical support
- Extreme short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF implied upside >60%
- Forward P/E well below industry
- Improving earnings trajectory
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Large cash buffer versus debt
- Potential macro‑economic stabilization in Argentina
- Significant valuation gap to fair value
Key Metrics & Analysis
Financial Health
Revenue Growth-29.80%
Profit Margin-6.66%
P/E Ratio6.0
ROE-4.66%
ROA-0.71%
P/B Ratio1.0
Op. Cash Flow$489.1B
Industry P/E17.5
Technical Analysis
TrendNeutral
RSI30.7
Support$7.66
Resistance$10.14
MA 20$9.31
MA 50$9.12
MA 200$9.50
MACDBearish
VolumeIncreasing
Fear & Greed Index91.09
Valuation
Fair Value$43,421.55
Target Price$12.80
Upside/Downside62.25%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.55
Volatility62.61%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.